Gang Xu

13.1k total citations · 3 hit papers
218 papers, 8.0k citations indexed

About

Gang Xu is a scholar working on Nephrology, Molecular Biology and Oncology. According to data from OpenAlex, Gang Xu has authored 218 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Nephrology, 53 papers in Molecular Biology and 47 papers in Oncology. Recurrent topics in Gang Xu's work include Chronic Kidney Disease and Diabetes (30 papers), Renal Diseases and Glomerulopathies (26 papers) and Acute Kidney Injury Research (21 papers). Gang Xu is often cited by papers focused on Chronic Kidney Disease and Diabetes (30 papers), Renal Diseases and Glomerulopathies (26 papers) and Acute Kidney Injury Research (21 papers). Gang Xu collaborates with scholars based in China, United States and Germany. Gang Xu's co-authors include Ying Yao, Shuwang Ge, Ran Luo, Yichun Cheng, Junhua Li, Lei Dong, Zhixiang Wang, Kun Wang, Meng Zhang and Rui Zeng and has published in prestigious journals such as The Journal of Experimental Medicine, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Gang Xu

209 papers receiving 7.9k citations

Hit Papers

Kidney disease is associa... 2016 2026 2019 2022 2020 2020 2016 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gang Xu China 39 2.2k 2.0k 2.0k 1.5k 1.1k 218 8.0k
Ying Yao China 30 2.0k 0.9× 995 0.5× 918 0.5× 822 0.5× 702 0.7× 110 4.6k
Efstathios Kastritis Greece 58 2.2k 1.0× 1.2k 0.6× 6.8k 3.5× 5.7k 3.7× 999 0.9× 583 15.0k
Glen S. Markowitz United States 63 1.1k 0.5× 7.0k 3.5× 3.7k 1.9× 1.2k 0.8× 1.3k 1.2× 195 13.5k
Bernhard O. Boehm Germany 59 1.3k 0.6× 454 0.2× 2.8k 1.4× 1.1k 0.7× 3.0k 2.8× 307 13.7k
Ariela Benigni Italy 77 1.1k 0.5× 5.6k 2.8× 5.8k 2.9× 853 0.6× 3.1k 2.9× 335 18.9k
Emmanuel J. Favaloro Australia 58 942 0.4× 442 0.2× 778 0.4× 645 0.4× 3.2k 3.0× 704 15.9k
Hartmut Schmidt Germany 46 868 0.4× 416 0.2× 3.8k 1.9× 1.2k 0.8× 1.7k 1.6× 360 9.2k
Xiaofeng Zeng China 42 927 0.4× 357 0.2× 1.4k 0.7× 633 0.4× 986 0.9× 488 9.2k
Jianhua Mao China 24 1.5k 0.7× 782 0.4× 1.0k 0.5× 317 0.2× 266 0.2× 184 4.1k
Lai‐Shan Tam Hong Kong 55 465 0.2× 717 0.4× 1.5k 0.7× 922 0.6× 874 0.8× 290 10.2k

Countries citing papers authored by Gang Xu

Since Specialization
Citations

This map shows the geographic impact of Gang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gang Xu more than expected).

Fields of papers citing papers by Gang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gang Xu. The network helps show where Gang Xu may publish in the future.

Co-authorship network of co-authors of Gang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Gang Xu. A scholar is included among the top collaborators of Gang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gang Xu. Gang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Ran, et al.. (2025). Identifying potential mechanism and targets for treatment of tertiary lymphoid structure in lupus nephritis based on bioinformatics analysis. International Immunopharmacology. 148. 114084–114084. 1 indexed citations
3.
Zhao, Ming‐Hui, Wei Chen, Hong Chen, et al.. (2024). A Chinese Multi-Specialty Delphi Consensus to Optimize RAASi Usage and Hyperkalaemia Management in Patients with Chronic Kidney Disease and Heart Failure. Chinese Medical Sciences Journal. 39(2). 79–90. 1 indexed citations
4.
Li, Hengyang, et al.. (2024). Redefinable neural network for structured light array. Advanced Photonics Nexus. 3(5). 2 indexed citations
5.
Cao, Dongxing, Nailin Yang, Gang Xu, et al.. (2023). Thymopentin ameliorates experimental colitis via inhibiting neutrophil extracellular traps. International Immunopharmacology. 124(Pt A). 110898–110898. 2 indexed citations
6.
Liu, Yuhan, et al.. (2023). Causal relationship between coffee intake and neurological diseases: a Mendelian randomization study. European Journal of Clinical Nutrition. 78(2). 114–119. 5 indexed citations
7.
Wang, Yuxi, Li‐Sheng Wang, Hui Tong, et al.. (2021). Immunoadsorption Improves Remission Rates of Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis and Severe Kidney Involvement. American Journal of Nephrology. 52(12). 899–908. 5 indexed citations
8.
Deng, Xuan, Cheng Zhou, Yi Guo, et al.. (2021). Separated parabiont reveals the fate and lifespan of peripheral-derived immune cells in normal and ischaemia-induced injured kidneys. Open Biology. 11(6). 200340–200340. 4 indexed citations
9.
Luo, Ran, et al.. (2021). Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital. BMC Infectious Diseases. 21(1). 397–397. 11 indexed citations
10.
Pei, Guangchang, Zhiguo Zhang, Jing Peng, et al.. (2020). Renal Involvement and Early Prognosis in Patients with COVID-19 Pneumonia. Journal of the American Society of Nephrology. 31(6). 1157–1165. 501 indexed citations breakdown →
11.
Yang, Ming, Naiguo Wang, Xiaoxin Xu, et al.. (2020). Facet joint parameters which may act as risk factors for chronic low back pain. Journal of Orthopaedic Surgery and Research. 15(1). 185–185. 15 indexed citations
12.
Chang, Xiaoyan, Qian Yang, Conghui Zhang, et al.. (2019). Roles for VEGF‐C/NRP–2 axis in regulating renal tubular epithelial cell survival and autophagy during serum deprivation. Cell Biochemistry and Function. 37(4). 290–300. 12 indexed citations
13.
Major, Rupert, Robert A. Grant, Saran Shantikumar, et al.. (2018). Cardiovascular disease risk factors in chronic kidney disease: A systematic review and meta-analysis. PLoS ONE. 13(3). e0192895–e0192895. 164 indexed citations
14.
Hu, Zhizhi, Nan Zhang, Chunxiu Zhang, et al.. (2017). Impact of arteriovenous fistula blood flow on serum il-6, cardiovascular events and death: An ambispective cohort analysis of 64 Chinese hemodialysis patients. PLoS ONE. 12(3). e0172490–e0172490. 9 indexed citations
15.
Xu, Xin, Guobao Wang, Nan Chen, et al.. (2016). Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China. Journal of the American Society of Nephrology. 27(12). 3739–3746. 338 indexed citations breakdown →
16.
Xu, Jianbo, et al.. (2016). Hepatocellular Carcinoma with Hypersplenic Thrombocytopenia and Situs Inversus Totalis: A Case Report. Chinese Medical Sciences Journal. 31(2). 134–136. 2 indexed citations
17.
Xu, Gang. (2014). The Interaction between Sytactic and Semantic Modules in Chinese Learners’ English Spotaneous Speech. English Language Teaching. 7(10). 1 indexed citations
18.
Zhou, Qiaodan, Yong Ning, Rui Zeng, et al.. (2013). Erbin interacts with Sema4C and inhibits Sema4C-induced epithelial-mesenchymal transition in HK2 cells. Journal of Huazhong University of Science and Technology [Medical Sciences]. 33(5). 672–679. 8 indexed citations
19.
Yang, Wanhua, Danfeng Luo, Shixuan Wang, et al.. (2008). TMTP1, a Novel Tumor-Homing Peptide Specifically Targeting Metastasis. Clinical Cancer Research. 14(17). 5494–5502. 96 indexed citations
20.
Wu, Jingyi, Liang Huang, Mei Huang, et al.. (2008). Dominant contribution of malignant endothelial cells to endotheliopoiesis in chronic myeloid leukemia. Experimental Hematology. 37(1). 87–91. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026